CD8A and melanoma: Tumeh and colleagues showed there was a lower density of CD8+ T cells at the invasive margins in liver versus non-liver metastases in patients with advanced melanoma in an effort to understand the liver-specific mechanisms of resistance to checkpoint inhibitor immunotherapy.